Ireland
--:--IST
Recruiting Not applicable

Effects of High Intensity Laser Therapy in Muscle Injuries

NCT06812611 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-12-01
Last updated
2026-05-14

Condition(s) studied

Muscle Tear

Investigational drug(s) / intervention(s)

High Energy Laser GroupExercise

High Energy Laser Group: The multimodal high energy laser therapy treatment with thermal control (THEAL) will be delivered with an Ixyon XP device (Mectronic, Bergamo, Italy) which allows the delivery of 4 wavelengths (650 nm, 810 nm, 980 nm and 1064 nm), with continuous and pulsed mode, average power up to 30 W, administering 10 sessions every other day. The patients will simultaneously carry out the rehabilitation treatment exercises, as was expected in the control group.

Exercise: Daily exercise

Study summary

Muscle injuries are frequent traumatic events in daily life, particularly during sports. In sports, their incidence varies from 10% to 55% of total injuries. According to the Mueller Wohlfart classification, muscle injuries are classified into direct traumatic injuries (contusion-laceration) and indirect traumatic injuries, which are further divided into non-structural injuries (grade I and II) and structural injuries. Structural lesions are further divided into partial muscle lesions (grade III): 3 A, minor partial lesion, i.e. lesion of one or more primary bundles with a secondary bundle; 3 B, moderate partial lesion, i.e. lesion of at least one secondary bundle and with a rupture area \< 50% of the muscle surface; and (sub)total muscle injury (grade IV).

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * presence of a grade III A muscle lesion of the lower limbs, according to the Mueller-Wohlfart classification, confirmed by ultrasound examination and occurred during sporting activity at least 5 days before inclusion in the study; * no previous muscle injury in the last 6 months; * signing of the written informed consent for participation in the study. Exclusion Criteria: * previous muscle injuries or bone fractures of the lower limbs in the last 6 months; * knee instability due to previous rupture of the knee ligaments; • instability or previous sprain of the ankle; * active neoplastic or infectious diseases; * contraindications to biostimulation; * congenital anomalies of the lower limbs.

Primary outcome measure(s)

  • recovery of pain — From enrollment to 3 weeks and 3 months
    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

Trial sites (1)

FacilityCityRegionStatus
Policlinico di Bari Bari Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06812611 on ClinicalTrials.gov ↗ ← All trials in Italy